Skip to content
Our reporters bring you news and highlights from BIO’s in-person and virtual events.
Even in this challenging market, biotechnology firms are attracting investment and building capital, but they need more than just a great innovation. They also […]
Biotech investment is scarce, but still available, experts tell CEOs Read More »
Mergers and acquisitions (M&A) are important elements of the biotech industry, especially for early-stage fundraising and bringing new drugs and treatments to the market.
What biotech companies should know about M&A in down markets Read More »
The metabolic field is the hottest biotech therapeutic area of the year (and likely to continue beyond). In the context of a difficult couple
The future of next-generation obesity drugs Read More »
Artificial intelligence and machine learning have boosted drug development and enhanced the value of biotech firms for years, but investors and companies need to
Drug developers and investors need to join AI revolution, panel says Read More »
The biotech industry must constantly navigate the ins and outs of Beltway politics. During an election year, the need to anticipate and plan for
What policy biotech should be watching this election year Read More »
The Biotechnology Innovations Organization (BIO) report, The State of Innovation in Vaccines and Prophylactic Antibodies for Infectious Diseases, on January 25, 2024, found that
CEOs explore challenges and opportunities in vaccine pipeline Read More »
The science of gene therapies is progressing at a remarkable pace, but if these medicines are going to reach patients, trends in investment and
CEOs say market must keep up with the science of gene therapies Read More »
The New York City Economic Development Corporation (NYCEDC) announced on February 26 that it’s seeking a private-sector anchor tenant for the Science Park and
NYCEDC seeks private-sector life sciences anchor tenant at SPARC Kips Bay Read More »
“If you want to go fast, go alone,” said Interim Dean of UCLA’s Division of Social Sciences, Abel Valenzuela Jr., giving opening remarks at
When Medicine Stops Saving Us: The Antimicrobial Resistance Crisis Read More »
J.P. Morgan’s massive Healthcare Conference wrapped last week. BIO was busy as ever in San Francisco, connecting companies with potential partners, discussing innovation, and
2024 JPM Healthcare Conference: top 5 BIO takeaways Read More »
